The researchers suggest the overexpression of inactive pRKIP in MM may contribute to the sustained activation of survival pathways, resulting in increased expression of oncogenes like Bcl-2 and decreased expression of pro-apoptotic genes like Fas [43]. The gene discussed is BCL2; the disease is Miyoshi myopathy.